Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-102666 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
21
Total Shares
881,269
Total Value
$18,786,349.55
P&L
+inf% (+$1,098,800.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 75,000 | $8.40 | $630,000.00 | 81,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 21,791 | $58.81 | $1,281,528.71 | 59,209 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 31,694 | $59.88 | $1,897,836.72 | 27,515 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 21,515 | $60.49 | $1,301,442.35 | 6,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 25,000 | $3.10 | $77,500.00 | 31,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 12,479 | $59.50 | $742,500.50 | 18,521 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 10,072 | $60.47 | $609,053.84 | 8,449 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 2,449 | $61.26 | $150,025.74 | 6,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 105,000 | $4.75 | $498,750.00 | 111,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 43,348 | $59.26 | $2,568,802.48 | 72,652 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 61,652 | $60.08 | $3,704,052.16 | 6,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 65,000 | $9.44 | $613,600.00 | 71,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Sale | 65,000 | $62.06 | $4,033,900.00 | 6,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 9, 2026 | Exercise/Conversion | 20,000 | โ | โ | 26,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Mar 10, 2026 | Sale | 11,269 | $60.11 | $677,357.05 | 14,731 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Mar 9, 2026 | Exercise/Conversion | 75,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Mar 9, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Mar 9, 2026 | Exercise/Conversion | 105,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Mar 9, 2026 | Exercise/Conversion | 65,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Performance Share Units | Derivative | Mar 9, 2026 | Grant/Award | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details | |
Director | Performance Share Units | Derivative | Mar 9, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |